AtlantiCare signed a letter of intent with John Brooks Recovery Center to acquire and become the parent company of JBRC, the companies announced Jan. 18.
The acquisition would allow AtlantiCare to expand its network of substance use disorder and behavioral health and wellness programs and services.
JBRC’s two outpatient centers and one residential treatment facility offer clinically-driven treatment options.
“The continuum of care is extremely important at AtlantiCare and John Brooks Recovery Center—it guides our vision of building healthy communities together,” said AtlantiCare President and Chief Executive Officer Lori Herndon. “AtlantiCare and JBRC also share a long history of providing compassionate care and support to individuals struggling with substance use disorders, as well as their loved ones.
“AtlantiCare’s mission is to make a difference in health and healing, one person at a time, through caring and trusting relationships,” she continued. “By combining our complementary behavioral health capabilities, we would broaden and deepen our ability to reach individuals in need and provide the continuum of care and support that is so essential to their long-term recovery and brighter futures.”
AtlantiCare and JBRC have partnered before.
AtlantiCare’s Federally Qualified Health Center in Atlantic City provides care coordination, primary care and other treatment services to JBRC clients; and the health care system links patients of AtlantiCare Regional Medical Center and its other care locations with JBRC’s services. Additionally, JBRC has participated in AtlantiCare’s “Healing. Hope. Recovery.” opioid response initiative, as well as other efforts aimed at creating a culture of recovery and eliminating the stigma of addiction.
“The signing of this letter of intent is an exciting next step in the collaborative relationship JBRC and AtlantiCare have fostered,” said JBRC CEO Michael Santillo in a prepared statement. “Our organizations are well versed in the unique assets, services and capabilities each brings to the table because we’ve been immersed in each other’s way of service for years. With this acquisition we would strategize even more effective ways to leverage our resources to make lives better for individuals suffering from substance use disorders regardless of financial circumstances or socio-economic background.”
The transaction is expected to be completed in early 2022, pending the signing of a definitive agreement and attaining regulatory approvals.